Alloga (nederland) B.v. Pharmaceutical Import Profile — Netherlands (DGFT 2022–2026)

Name: Alloga (nederland) B.v. Pharmaceutical Import Records from India — 3 Products, $1.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Alloga (nederland) B.v. — Pharmaceutical Importer Profile (2026) | 3 Products, $1.5M Trade | TransData Nexus

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Brufen	Brand Names & OTC Products	$994.9K	42	8.9%	3
2	Leflunomide	Immunosuppressants	$260.0K	18	1.7%	11
3	Fenofibrate	Lipid & Metabolism	$200.0K	4	0.3%	16

Alloga (nederland) B.v. imports 3 pharmaceutical products across 3 categories into Netherlands totaling $1.5M.

Alloga (nederland) B.v. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Alloga (Nederland) B.V., established in 1998, is a Dutch company specializing in logistics services, particularly within the pharmaceutical sector. Headquartered at De Amert 603, 5462 GH Veghel, Netherlands, it operates under the legal form of a Besloten Vennootschap (private limited company) with registration number 17108476. The company is part of the Alloga network, a pan-European pharmaceutical logistics provider, offering services tailored to the specific requirements of each country or region.

Alloga (Nederland) B.V. plays a significant role in the Netherlands' pharmaceutical distribution chain by providing comprehensive logistics solutions. These services include storage, order fulfillment, packaging, and distribution of pharmaceutical products, ensuring compliance with Good Manufacturing Practice (GMP) standards. (alloga.nl) The company's expertise extends to handling both prescription and over-the-counter medications, catering to various stakeholders such as pharmacies, hospital groups, and healthcare providers.

2Distribution Network

Alloga (Nederland) B.V. operates a centralized distribution center located at De Amert 603, 5462 GH Veghel, Netherlands. This facility is strategically positioned to serve the Benelux region, encompassing Belgium, the Netherlands, and Luxembourg. The company's logistics capabilities are designed to ensure efficient storage and distribution of pharmaceutical products, adhering to stringent regulatory standards. While specific details about additional warehouse locations or geographic coverage beyond the Benelux region are not publicly disclosed, Alloga's affiliation with the pan-European Alloga network suggests potential access to a broader distribution infrastructure across Europe.

3Industry Role

Alloga (Nederland) B.V. functions primarily as a logistics intermediary within the Netherlands' pharmaceutical supply chain. Its core activities include the storage, packaging, and distribution of pharmaceutical products, ensuring that medications reach their intended destinations in compliance with regulatory standards. The company's services are integral to the efficient operation of the pharmaceutical sector, supporting various stakeholders such as pharmaceutical manufacturers, wholesalers, and healthcare providers. By managing the complexities of pharmaceutical logistics, Alloga (Nederland) B.V. contributes to the overall effectiveness and reliability of the supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Alloga (nederland) B.v.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Alloga (Nederland) B.V. imports finished pharmaceutical formulations from India, with a total import value of $1.5 million USD across 64 shipments. The product portfolio comprises three products across three therapeutic categories, with the top five products accounting for 100% of the imports. This indicates a high level of concentration in sourcing, which could pose risks such as supply chain disruptions or dependency on a limited number of suppliers. However, the strategic choice to focus on a select range of products may also allow for streamlined operations and specialized expertise in these areas. The stability of the relationship with Indian suppliers is crucial, and the consistent import pattern over the years suggests a reliable and ongoing partnership.

2Supply Chain Resilience

The resilience of Alloga (Nederland) B.V.'s supply chain is closely tied to its relationship with Indian suppliers. The company's focus on a limited number of products imported from India suggests a strategic sourcing approach, potentially allowing for better quality control and cost management. However, this concentration also means that any disruptions in the Indian supply chain—such as regulatory changes, production issues, or logistical challenges—could significantly impact Alloga's operations. To mitigate these risks, it would be prudent for Alloga to establish contingency plans, including identifying alternative suppliers and diversifying its product range. Ensuring that key suppliers comply with international regulatory standards, such as Good Manufacturing Practice (GMP), is essential for maintaining the integrity and reliability of the supply chain.

Importing Pharmaceuticals into Netherlands — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Netherlands

1Regulatory Authority & Framework

In the Netherlands, the Dutch Medicines Evaluation Board (CBG-MEB) is the primary regulatory authority responsible for the evaluation and supervision of pharmaceutical products. The CBG-MEB ensures that medicines available in the Netherlands are effective, safe, and of high quality. Key legislation governing pharmaceutical imports includes the Medicines Act (Geneesmiddelenwet), which outlines the requirements for the marketing, import, and distribution of medicinal products. The marketing authorization pathway for Indian generics involves obtaining a marketing authorization from the CBG-MEB, which may include demonstrating bioequivalence to the reference product and compliance with Good Manufacturing Practice (GMP) standards.

2Import Licensing & GMP

Import licensing requirements in the Netherlands stipulate that pharmaceutical products must be authorized by the CBG-MEB before they can be marketed. Manufacturers and importers must hold a valid wholesale distribution authorization, which requires compliance with Good Distribution Practice (GDP) and GMP standards. GMP certificates recognized by the CBG-MEB include those issued by the European Union (EU GMP), the World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications ensure that manufacturing processes meet international quality standards, which is crucial for the safety and efficacy of pharmaceutical products.

Alloga (nederland) B.v. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Alloga (Nederland) B.V.'s focus on importing finished pharmaceutical formulations in the therapeutic categories of Brand Names & OTC Products, Immunosuppressants, and Lipid & Metabolism indicates a strategic alignment with market demand. The substantial import value of Brufen, a nonsteroidal anti-inflammatory drug (NSAID), suggests a strong market demand for pain management and anti-inflammatory treatments. The inclusion of Leflunomide and Fenofibrate reflects a commitment to providing essential medications for chronic conditions such as rheumatoid arthritis and hyperlipidemia, respectively. This product strategy positions Alloga to meet critical healthcare needs within the Netherlands.

2Sourcing Profile

Alloga (Nederland) B.V. employs a sourcing strategy that focuses on importing finished pharmaceutical formulations from India, a country known for its robust pharmaceutical manufacturing sector. The company's preference for finished products over active pharmaceutical ingredients (APIs) suggests a focus on ready-to-market solutions that can be efficiently distributed within the Netherlands. India's compliance with international quality standards, such as GMP, aligns with Alloga's commitment to ensuring the safety and efficacy of the products it distributes.

3Market Positioning

Seller's Guide — How to Become a Supplier to Alloga (nederland) B.v.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Alloga (Nederland) B.V., particularly if they can offer high-quality finished pharmaceutical formulations that meet the therapeutic needs identified in Alloga's product strategy. Gaps in Alloga's current sourcing may exist in areas such as emerging therapeutic categories or innovative drug formulations. Indian exporters can explore these opportunities by ensuring compliance with international quality standards, providing competitive pricing, and demonstrating a commitment to reliable supply chain practices.

2Requirements & Qualifications

Indian exporters seeking to supply Alloga (Nederland) B.V. and the Netherlands market must obtain marketing authorization from the Dutch Medicines Evaluation Board (CBG-MEB). This requires compliance with Good Manufacturing Practice (GMP) standards, with certifications recognized by the EU, WHO, or PIC/S. Additionally, products must meet labeling requirements in Dutch and adhere to serialization mandates to ensure traceability and

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Alloga (nederland) B.v.

What products does Alloga (nederland) B.v. import from India?

Alloga (nederland) B.v. imports 3 pharmaceutical products across 3 categories. Top imports: Brufen ($994.9K), Leflunomide ($260.0K), Fenofibrate ($200.0K).

What is Alloga (nederland) B.v.'s total pharmaceutical import value?

Alloga (nederland) B.v.'s total pharmaceutical import value from India is $1.5M, based on 64 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Alloga (nederland) B.v. focus on?

Alloga (nederland) B.v. imports across 3 categories. The largest: Brand Names & OTC Products (68.4%), Immunosuppressants (17.9%), Lipid & Metabolism (13.7%).

Get Full Alloga (nederland) B.v. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 5 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Alloga (nederland) B.v.

Alloga (nederland) B.v. — Import Portfolio & Supplier Network

What Products Does Alloga (nederland) B.v. Import?

Top Products by Import Value

Alloga (nederland) B.v. Therapeutic Categories — 3 Specializations